Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates
Open Access
- 18 February 2016
- journal article
- other
- Published by Elsevier BV in Stem Cell Reports
- Vol. 6 (3), 312-320
- https://doi.org/10.1016/j.stemcr.2016.01.012
Abstract
No abstract availableKeywords
Funding Information
- Japan Science and Technology Agency
This publication has 24 references indexed in Scilit:
- An Efficient Nonviral Method to Generate Integration-Free Human-Induced Pluripotent Stem Cells from Cord Blood and Peripheral Blood CellsThe International Journal of Cell Cloning, 2013
- Bioengineered Myocardium Derived from Induced Pluripotent Stem Cells Improves Cardiac Function and Attenuates Cardiac Remodeling Following Chronic Myocardial Infarction in RatsStem Cells Translational Medicine, 2012
- Laminin E8 fragments support efficient adhesion and expansion of dissociated human pluripotent stem cellsNature Communications, 2012
- iPS cells: A source of cardiac regenerationJournal of Molecular and Cellular Cardiology, 2011
- Recent Stem Cell Advances: Induced Pluripotent Stem Cells for Disease Modeling and Stem Cell–Based RegenerationCirculation, 2010
- HLA-haplotype banking and iPS cellsNature Biotechnology, 2008
- Novel cynomolgus macaque MHC‐DPB1 polymorphisms in three South‐East Asian populations*Tissue Antigens, 2006
- Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcomeBlood, 2004
- The failing heartNature, 2002
- Immune response to green fluorescent protein: implications for gene therapyGene Therapy, 1999